Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08WQO
|
||||
| Former ID |
DNC012653
|
||||
| Drug Name |
2-(1-Pentyl-hexyl)-4-phenyl-1H-imidazole
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H30N2
|
||||
| Canonical SMILES |
CCCCCC(CCCCC)C1=NC=C(N1)C2=CC=CC=C2
|
||||
| InChI |
1S/C20H30N2/c1-3-5-8-14-18(15-9-6-4-2)20-21-16-19(22-20)17-12-10-7-11-13-17/h7,10-13,16,18H,3-6,8-9,14-15H2,1-2H3,(H,21,22)
|
||||
| InChIKey |
XYWGMJFQZHLYDO-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Inhibitor | [1] | |
| Voltage-gated sodium channel subunit alpha Nav1.3 | Target Info | Inhibitor | [1] | ||
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and AnkyrinsR-HSA-445095:Interaction between L1 and Ankyrins | ||||
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.